Todd Wallach

Todd Wallach has a diverse work experience in various leadership roles. In 2021, they served as the CEO at SOLUtion Medical and OncoSTING. Todd was also an Entrepreneur in Residence at Delaware Innovation Space and the University of Colorado Boulder. Prior to these roles, they were the Chief Technology Officer at Moon Mark and a Member of The Explorers Club. From 2015 to 2021, they held the position of President and CEO at Evogen, Inc. and Cognizance Biomarkers, LLC. Before that, they served as the CEO and Chairman of Molecular Detection, Inc. and as the Chief Financial Officer of Aton Pharma, Inc. Todd also worked as the Vice President of Finance & Operations at Acuity Pharmaceuticals.

Todd Wallach's education history includes a Master of Science in Management of Technology from the University of Pennsylvania Wharton / SEAS, which they obtained between 1998 and 2000. In 2002, they earned a Master's degree in Biotechnology from the University of Pennsylvania. Prior to that, Todd Wallach completed an MBA in Management and Finance at Rider University from 1986 to 1991. Their undergraduate degree is a Bachelor of Science in Mechanical Engineering from Purdue University, which they completed between 1983 and 1986.